Analysis of cerebrospinal fluid glucose levels shows links to disability and depression in multiple sclerosis, suggesting metabolic impacts on brain health.
Key Points
This research examines the relationship between cerebrospinal fluid glucose levels and clinical outcomes in newly diagnosed multiple sclerosis patients.
Analyzed data from 88 treatment-naive, newly diagnosed MS patients.
Measured cerebrospinal fluid and serum glucose levels along with clinical outcomes like EDSS and SDMT.
Used linear regression to assess the association between CSF glucose and clinical parameters, adjusting for age, sex, and BMI.
Significant association found between CSF glucose levels and Expanded Disability Status Scale (EDSS).
CSF glucose negatively correlated with Symbol Digit Modalities Test (SDMT) scores.
Higher CSF glucose concentrations linked to worse depression as per Beck Depression Inventory-II.